Provided by Tiger Fintech (Singapore) Pte. Ltd.

ARCELLX, INC.

63.00
-0.8200-1.28%
Post-market: 63.000.00000.00%18:07 EDT
Volume:986.91K
Turnover:61.72M
Market Cap:3.47B
PE:-21.02
High:64.64
Open:64.25
Low:60.92
Close:63.82
Loading ...

Arcellx Shares up 1.9% After Citigroup Initiates Coverage With Buy Rating

THOMSON REUTERS
·
17 Jun

Arcellx Initiated at Buy by Citigroup

Dow Jones
·
17 Jun

Arcellx Shares up 2.7% Premarket After Citigroup Initiates Coverage With Buy Rating

THOMSON REUTERS
·
17 Jun

Citigroup Initiates Arcellx at Buy With $110 Price Target

MT Newswires Live
·
17 Jun

Arcellx initiated with a Buy at Citi

TIPRANKS
·
17 Jun

Arcellx Price Target Maintained With a $115.00/Share by HC Wainwright & Co.

Dow Jones
·
16 Jun

Barclays Keeps Their Buy Rating on Arcellx Inc (ACLX)

TIPRANKS
·
04 Jun

Arcellx Inc. CFO Michelle Gilson Reports Disposal of Common Shares

Reuters
·
29 May

Arcellx Inc. Conducted Annual Stockholders Meeting

Reuters
·
29 May

Arcellx Announces Its Participation at TD Cowen’s 6TH Annual Oncology Innovation Summit and Its Investor Event During Eha2025

THOMSON REUTERS
·
22 May

Analysts Offer Insights on Healthcare Companies: Centessa Pharmaceuticals (CNTA), Arcellx Inc (ACLX) and Belite Bio, Inc. ADR (BLTE)

TIPRANKS
·
19 May

Stock Track | Arcellx Plummets 5.14% Despite Announcing Positive Study Data, Raising Market Concerns

Stock Track
·
16 May

Stock Track | Arcellx Plummets 5.14% Despite Announcing Positive Study Data, Raising Market Concerns

Stock Track
·
14 May

Arcellx's Potential Multiple Myeloma Treatment Shows 97% Overall Response Rate in Phase 2 Study; Shares Rise

MT Newswires Live
·
14 May

Arcellx announces data from iMMagine-1 study of anitocabtagene autoleucel

TIPRANKS
·
14 May

Stock Track | Arcellx (ACLX) Soars 5.56% on Positive Data from Multiple Myeloma Study

Stock Track
·
14 May

Arcellx Announces New Positive Data for Its Immagine-1 Study in Patients With Relapsed and/or Refractory Multiple Myeloma

THOMSON REUTERS
·
14 May

Arcellx Is Maintained at Sector Outperform by Scotiabank

Dow Jones
·
10 May

Piper Sandler Remains a Buy on Arcellx Inc (ACLX)

TIPRANKS
·
09 May

Arcellx price target lowered to $93 from $133 at Scotiabank

TIPRANKS
·
09 May